You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TIGIT inhibitor

Showing 1 - 25 of 7,387
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Trial in Pittsburgh (Zimberelimab, Domvanalimab)

Recruiting
  • Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Apr 11, 2022

Advanced Cancer, Ovarian Cancer, Lung Cancer Trial in United States (Dose escalation: COM902 monotherapy., Evaluation of

Recruiting
  • Advanced Cancer
  • +6 more
  • Dose escalation: COM902 monotherapy.
  • +3 more
  • Grand Rapids, Michigan
  • +5 more
Aug 8, 2022

Metastatic Solid Tumors Trial in Canada, United States (M6223, Bintrafusp alfa)

Recruiting
  • Metastatic Solid Tumors
  • Nashville, Tennessee
  • +3 more
Oct 14, 2021

Non-Small-Cell Lung Carcinoma Trial in Worldwide (AZD2936)

Recruiting
  • Non-Small-Cell Lung Carcinoma
  • Orange, California
  • +29 more
Aug 18, 2022

Advanced Solid Tumor, NSCLC, Hepatocellular Carcinoma Trial in Canton (CHS-006 (anti-TIGIT), toripalimab (anti-PD-1))

Not yet recruiting
  • Advanced Solid Tumor
  • +2 more
  • CHS-006 (anti-TIGIT)
  • toripalimab (anti-PD-1)
  • Canton, Ohio
    Gabrail Cancer and Research Center
Feb 23, 2023

Advanced Malignant Tumors Trial (AK127 Q3W IV infusion ,AK104 10mg/kg Q3W IV infusion)

Not yet recruiting
  • Advanced Malignant Tumors
  • AK127 Q3W IV infusion ,AK104 10mg/kg Q3W IV infusion
  • (no location specified)
May 11, 2023

Endometrial Tumors, Ovarian Cancer, Solid Tumor Trial in United States (COM701 in combination with BMS-986207 and nivolumab.)

Recruiting
  • Endometrial Neoplasms
  • +3 more
  • COM701 in combination with BMS-986207 and nivolumab.
  • Chicago, Illinois
  • +8 more
Aug 8, 2022

Renal Cell Carcinoma Trial in Beijing, Seoul (RO7247669, Tiragolumab, Pembrolizumab)

Recruiting
  • Renal Cell Carcinoma
  • Beijing, China
  • +1 more
Mar 28, 2023

Advanced Tumor Trial (PM1009 injection)

Not yet recruiting
  • Advanced Tumor
  • PM1009 injection
  • (no location specified)
Nov 7, 2022

Solid Tumor, Adult, Advanced Solid Tumor, Metastatic Solid Tumor Trial in United Kingdom, United States (Etigilimab dosing,

Recruiting
  • Solid Tumor, Adult
  • +2 more
  • Phoenix, Arizona
  • +15 more
Jun 6, 2022

Gastrointestinal Tract Malignancies Trial in Sarasota, Nashville (Zimberelimab, Domvanalimab, Fluorouracil)

Recruiting
  • Gastrointestinal Tract Malignancies
  • Phoenix, Arizona
  • +26 more
Jan 20, 2023

Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)

Recruiting
  • Advanced Cancer
  • +9 more
  • COM701
  • COM701 with Opdivo (Nivolumab).
  • Los Angeles, California
  • +10 more
Jan 25, 2022

Carcinoma, Hepatocellular Trial (Atezolizumab, Bevacizumab, Tiragolumab)

Not yet recruiting
  • Carcinoma, Hepatocellular
  • (no location specified)
Jun 14, 2023

Advanced Malignant Tumors Trial (AK130)

Not yet recruiting
  • Advanced Malignant Tumors
  • (no location specified)
Dec 7, 2022

Head and Neck Tumors, MSI-H Cancer, Melanoma Trial (Tiragolumab and atezolizumab)

Not yet recruiting
  • Head and Neck Neoplasms
  • +2 more
  • Tiragolumab and atezolizumab
  • (no location specified)
Aug 1, 2022

Solid Tumor, Adult Trial in Albury (Tiragolumab, Atezolizumab)

Not yet recruiting
  • Solid Tumor, Adult
  • Tiragolumab
  • Atezolizumab
  • Albury, New South Wales, Australia
  • +1 more
Aug 22, 2023

Melanoma Trial in Worldwide (Pembrolizumab, Quavonlimab, Vibostolimab)

Recruiting
  • Melanoma
  • Pembrolizumab
  • +4 more
  • Los Angeles, California
  • +34 more
Jan 25, 2023

Advanced Upper Gastrointestinal Tract Adenocarcinoma Trial in United States (Zimberelimab, Domvanalimab, Nivolumab)

Recruiting
  • Advanced Upper Gastrointestinal Tract Adenocarcinoma
  • Hot Springs, Arkansas
  • +11 more
Dec 6, 2022

Non Small Cell Lung Cancer, Non-small Cell Carcinoma, NSCLC Trial in Saint Louis (Zimberelimab, Domvanalimab, Etrumadenant)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 8, 2022

Locally Advanced and Metastatic Solid Tumors Trial in Worldwide (Ociperlimab, Tislelizumab, Pemetrexed)

Recruiting
  • Locally Advanced and Metastatic Solid Tumors
  • Phoenix, Arizona
  • +66 more
May 16, 2022

Advanced/Metastatic Solid Tumors or Lymphoma Trial (HLX53)

Not yet recruiting
  • Advanced/Metastatic Solid Tumors or Lymphoma
  • HLX53
  • (no location specified)
May 23, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage IIIA Cutaneous

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +5 more
  • Jacksonville, Florida
  • +2 more
Oct 21, 2022

Metastatic Malignancy Trial in Houston (Atezolizumab, Tiragolumab)

Not yet recruiting
  • Metastatic Malignancy
  • Houston, Texas
    M D Anderson Cancer Center
Dec 19, 2022

Advanced Solid Tumours Trial (PM1021, PM8001)

Not yet recruiting
  • Advanced Solid Tumours
  • PM1021, PM8001
  • (no location specified)
Sep 12, 2022

Melanoma Trial (Blood samples, Skin biopsy)

Not yet recruiting
  • Melanoma
  • Blood samples
  • Skin biopsy
  • (no location specified)
Oct 3, 2022